ID

15192

Beschrijving

Genomic Response Analysis of Heart Failure Therapy in African Americans; ODM derived from: https://clinicaltrials.gov/show/NCT02305095

Link

https://clinicaltrials.gov/show/NCT02305095

Trefwoorden

Versies (1)
  1. 22-05-16 22-05-16 -
Geüploaded op

22 mei 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Heart Failure NCT02305095

Engels

Eligibility Heart Failure NCT02305095

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years and older
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
history of heart failure with an lvef (less than or equal to) < 0.35 for at least 6 months or an lvef < 0.45 with left ventricular internal end diastole (defined by a diameter of more than 2.9 cm per square meter of body surface area or more than 6.5 cm on the basis of echocardiography).
Beschrijving

Heart failure | Left ventricular ejection fraction | Diastolic left ventricular internal diameter End diastole | Body Surface Area | Echocardiography

Datatype

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0428772
UMLS CUI [3,1]
C0919652
UMLS CUI [3,2]
C1562146
UMLS CUI [4]
C0005902
UMLS CUI [5]
C0013516
new york heart association (nyha) class ii-iv
Beschrijving

New York Heart Association Classification

Datatype

boolean

Alias
UMLS CUI [1]
C1275491
background heart failure therapy that includes angiotensin converting enzyme inhibitors (acei) or angiotensin receptor blockers (arbs), and beta blockers (bbs) for at least 3 months (or documentation of intolerance to acei/arbs and bbs)
Beschrijving

Therapeutic procedure Background Heart failure | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Adrenergic beta-Antagonists | intolerance to Angiotensin-Converting Enzyme Inhibitors | intolerance to Angiotensin II receptor antagonist | intolerance to Adrenergic beta-Antagonists ,

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1706907
UMLS CUI [1,3]
C0018801
UMLS CUI [2]
C0003015
UMLS CUI [3]
C0521942
UMLS CUI [4]
C0001645
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0003015
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C0521942
UMLS CUI [7,1]
C1744706
UMLS CUI [7,2]
C0001645
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
no history of intolerance to either nitrates or hydralazine
Beschrijving

intolerance to Nitrates | intolerance to Hydralazine

Datatype

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0028125
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0020223
no treatment with the combination of hydralazine and nitrates for the previous 3 months
Beschrijving

Combination Drug Therapy Hydralazine Nitrates

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013218
UMLS CUI [1,2]
C0020223
UMLS CUI [1,3]
C0028125
no revascularization or myocardial infarction within last 90 days
Beschrijving

Revascularization | Myocardial Infarction

Datatype

boolean

Alias
UMLS CUI [1]
C0581603
UMLS CUI [2]
C0027051
can not be enrolled for at least 90 days after receiving cardiac resynchronization therapy (crt) and must have an lvef (less than or equal to) < 0.35 at least 3 months after crt.
Beschrijving

Cardiac Resynchronization Therapy | Left ventricular ejection fraction

Datatype

boolean

Alias
UMLS CUI [1]
C1167956
UMLS CUI [2]
C0428772
presence of clinically significant valvular heart disease, hypertrophic or restrictive cardiomyopathy, active myocarditis, or uncontrolled hypertension.
Beschrijving

Heart valve disease | Hypertrophic Cardiomyopathy | Restrictive cardiomyopathy | myocarditis; active | Uncontrolled hypertension

Datatype

boolean

Alias
UMLS CUI [1]
C0018824
UMLS CUI [2]
C0007194
UMLS CUI [3]
C0007196
UMLS CUI [4]
C0238294
UMLS CUI [5]
C1868885
women who are currently pregnant, planning on becoming pregnant in the next two years, or those who do not agree to prevent pregnancy.
Beschrijving

Pregnancy | Pregnancy, Planned | Pregnancy Preventing Unwilling

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3,1]
C0032961
UMLS CUI [3,2]
C1292733
UMLS CUI [3,3]
C0558080
Terug naar het begin van de pagina

Similar models

Eligibility Heart Failure NCT02305095

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years and older
boolean
C0001779 (UMLS CUI [1])
Heart failure | Left ventricular ejection fraction | Diastolic left ventricular internal diameter End diastole | Body Surface Area | Echocardiography
Item
history of heart failure with an lvef (less than or equal to) < 0.35 for at least 6 months or an lvef < 0.45 with left ventricular internal end diastole (defined by a diameter of more than 2.9 cm per square meter of body surface area or more than 6.5 cm on the basis of echocardiography).
boolean
C0018801 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
C0919652 (UMLS CUI [3,1])
C1562146 (UMLS CUI [3,2])
C0005902 (UMLS CUI [4])
C0013516 (UMLS CUI [5])
New York Heart Association Classification
Item
new york heart association (nyha) class ii-iv
boolean
C1275491 (UMLS CUI [1])
Therapeutic procedure Background Heart failure | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Adrenergic beta-Antagonists | intolerance to Angiotensin-Converting Enzyme Inhibitors | intolerance to Angiotensin II receptor antagonist | intolerance to Adrenergic beta-Antagonists ,
Item
background heart failure therapy that includes angiotensin converting enzyme inhibitors (acei) or angiotensin receptor blockers (arbs), and beta blockers (bbs) for at least 3 months (or documentation of intolerance to acei/arbs and bbs)
boolean
C0087111 (UMLS CUI [1,1])
C1706907 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
C0003015 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
C0001645 (UMLS CUI [4])
C1744706 (UMLS CUI [5,1])
C0003015 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C0521942 (UMLS CUI [6,2])
C1744706 (UMLS CUI [7,1])
C0001645 (UMLS CUI [7,2])
Item Group
C0680251 (UMLS CUI)
intolerance to Nitrates | intolerance to Hydralazine
Item
no history of intolerance to either nitrates or hydralazine
boolean
C1744706 (UMLS CUI [1,1])
C0028125 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0020223 (UMLS CUI [2,2])
Combination Drug Therapy Hydralazine Nitrates
Item
no treatment with the combination of hydralazine and nitrates for the previous 3 months
boolean
C0013218 (UMLS CUI [1,1])
C0020223 (UMLS CUI [1,2])
C0028125 (UMLS CUI [1,3])
Revascularization | Myocardial Infarction
Item
no revascularization or myocardial infarction within last 90 days
boolean
C0581603 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Cardiac Resynchronization Therapy | Left ventricular ejection fraction
Item
can not be enrolled for at least 90 days after receiving cardiac resynchronization therapy (crt) and must have an lvef (less than or equal to) < 0.35 at least 3 months after crt.
boolean
C1167956 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
Heart valve disease | Hypertrophic Cardiomyopathy | Restrictive cardiomyopathy | myocarditis; active | Uncontrolled hypertension
Item
presence of clinically significant valvular heart disease, hypertrophic or restrictive cardiomyopathy, active myocarditis, or uncontrolled hypertension.
boolean
C0018824 (UMLS CUI [1])
C0007194 (UMLS CUI [2])
C0007196 (UMLS CUI [3])
C0238294 (UMLS CUI [4])
C1868885 (UMLS CUI [5])
Pregnancy | Pregnancy, Planned | Pregnancy Preventing Unwilling
Item
women who are currently pregnant, planning on becoming pregnant in the next two years, or those who do not agree to prevent pregnancy.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1292733 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial